Literature DB >> 3918800

Pharmacokinetics of 5-fluorouracil infusions in the rat: comparison with man and other species.

J M Collins.   

Abstract

Saturable elimination of 5-FU is exhibited in rats during constant infusions. Over the range of 3-480 mg/m2/h, total-body clearance of 5-FU decreases from 600 ml/min/m2 to less than 90 ml/min/m2. Previously published values for catabolism of 5-FU by rat hepatocytes can be used to simulate the plasma concentrations of 5-FU that were measured over this range of infusions. The qualitative pattern of nonlinear pharmacokinetics for 5-FU is similar in rats, dogs, monkeys, and humans. However, there are major quantitative differences in total-body clearance values, expressed in terms of surface area (ml/min/m2) or as a fraction of cardiac output. Rat and monkey have substantially lower 5-FU clearance values than dog and man. Although 5-FU clearance values were similar in dogs and humans, total body clearance values for thymidine are 18-fold higher in humans than in dogs. The selection of an appropriate animal model to pursue the clinical observations of high total body clearance of pyrimidines remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918800     DOI: 10.1007/bf00434346

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  15 in total

1.  A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.

Authors:  W D Ensminger; A Rosowsky; V Raso; D C Levin; M Glode; S Come; G Steele; E Frei
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  Contribution of lungs to total body clearance: linear and nonlinear effects.

Authors:  J M Collins; R L Dedrick
Journal:  J Pharm Sci       Date:  1982-01       Impact factor: 3.534

3.  Concentration-dependent disappearance of fluorouracil from peritoneal fluid in the rat: experimental observations and distributed modeling.

Authors:  J M Collins; R L Dedrick; M F Flessner; A M Guarino
Journal:  J Pharm Sci       Date:  1982-07       Impact factor: 3.534

4.  Measurement of liver blood flow in the rat using an 85Krypton clearance technique.

Authors:  G C Rice; C J Ryan; D P Leiberman; R T Mathie; E McGhee; A M Harper; L H Blumgart
Journal:  Br J Exp Pathol       Date:  1977-06

5.  Nonlinear pharmacokinetics of thymidine, thymine, and fluorouracil and their kinetic interactions in normal dogs.

Authors:  J M Covey; J A Straw
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

6.  Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey.

Authors:  I G Kerr; S Zimm; J M Collins; D O'Neill; D G Poplack
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

7.  Pharmacokinetic studies of 5-fluorouracil and 5'-deoxy-5-fluorouridine in rats.

Authors:  J L Au; J S Walker; Y Rustum
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

8.  Nonlinear pharmacokinetic models for 5-fluorouracil in man: intravenous and intraperitoneal routes.

Authors:  J M Collins; R L Dedrick; F G King; J L Speyer; C E Myers
Journal:  Clin Pharmacol Ther       Date:  1980-08       Impact factor: 6.875

9.  Thymidine rescue of high-dose methotrexate in humans.

Authors:  S B Howell; W D Ensminger; A Krishan; E Frei
Journal:  Cancer Res       Date:  1978-02       Impact factor: 12.701

10.  Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver.

Authors:  E R Weibel; W Stäubli; H R Gnägi; F A Hess
Journal:  J Cell Biol       Date:  1969-07       Impact factor: 10.539

View more
  3 in total

Review 1.  Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.

Authors:  P Chrisp; D McTavish
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

Review 2.  Modulation of tumor cell response to chemotherapy by the organ environment.

Authors:  I J Fidler; C Wilmanns; A Staroselsky; R Radinsky; Z Dong; D Fan
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

3.  Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma.

Authors:  G J Peters; J Lankelma; R M Kok; P Noordhuis; C J van Groeningen; C L van der Wilt; S Meyer; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.